Vascular Endothelial Growth Factor C (VEGFC) Antibody

Product specifications

Primary Antibodies

Vascular Endothelial Growth Factor C (VEGFC)

Rabbit

Chicken

WB: 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user.

Polyclonal

Unconjugated

Purified by antigen-specific affinity chromatography, followed by Protein A affinity chromatography.

100 µl

200 µl

1 ml

Liquid

WB, IHC, IF/ICC

0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.

Shipped within 5-7 working days.

Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.

No

VRP,Flt4-L,LMPH1D,LMPHM4,Vascular endothelial growth factor-related protein

Antibody anti-VEGFC

RUO

Descripción

VEGFC is primarily responsible for lymphangiogenesis, the formation of lymphatic vessels, by binding to VEGFR-3 on lymphatic endothelial cells During embryonic development and tissue repair, VEGFC promotes the sprouting and maturation of lymphatic vessels VEGFC also activates VEGFR-2 in certain contexts, contributing to angiogenesis and vascular remodeling VEGFC plays a significant role in pathological processes, including cancer metastasis, where it enhances lymphatic vessel growth and facilitates tumor cell dissemination via the lymphatic system Overexpression of VEGFC is observed in various cancers such as breast cancer, melanoma, and prostate cancer, correlating with lymph node metastasis Targeting VEGFC signaling is a promising strategy to inhibit lymphangiogenesis and reduce cancer spread while maintaining tissue fluid balance and immune cell trafficking

Related Products

Human VEGF-C (Vascular Endothelial Growth Factor C) ELISA Kit

Ver Producto

Mouse VEGFC (Vascular endothelial growth factor C) ELISA Kit

Ver Producto

Rat VEGF-C (Vascular Endothelial Cell Growth Factor C) ELISA Kit

Ver Producto